213 related articles for article (PubMed ID: 8091066)
1. Hereditary ovarian carcinoma.
Gallion HH; Smith SA
Semin Surg Oncol; 1994; 10(4):249-54. PubMed ID: 8091066
[TBL] [Abstract][Full Text] [Related]
2. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
3. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton DF; Ford D; Bishop DT
Am J Hum Genet; 1995 Jan; 56(1):265-71. PubMed ID: 7825587
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
Easton DF; Bishop DT; Ford D; Crockford GP
Am J Hum Genet; 1993 Apr; 52(4):678-701. PubMed ID: 8460634
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
Narod SA; Ford D; Devilee P; Barkardottir RB; Lynch HT; Smith SA; Ponder BA; Weber BL; Garber JE; Birch JM
Am J Hum Genet; 1995 Jan; 56(1):254-64. PubMed ID: 7825586
[TBL] [Abstract][Full Text] [Related]
7. Genetic testing by cancer site: ovary.
Weissman SM; Weiss SM; Newlin AC
Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
[TBL] [Abstract][Full Text] [Related]
8. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
9. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
[TBL] [Abstract][Full Text] [Related]
10. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
[TBL] [Abstract][Full Text] [Related]
11. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for cancer predisposition.
Eng C; Hampel H; de la Chapelle A
Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome.
Zelada-Hedman M; Torroella M; Mesquita R; Nordenskjöld M; Skoog L; Lindblom A
Hum Genet; 1994 Sep; 94(3):231-4. PubMed ID: 8076936
[TBL] [Abstract][Full Text] [Related]
14. Hereditary ovarian cancer. Heterogeneity in age at onset.
Lynch HT; Watson P; Lynch JF; Conway TA; Fili M
Cancer; 1993 Jan; 71(2 Suppl):573-81. PubMed ID: 8420679
[TBL] [Abstract][Full Text] [Related]
15. Linkage studies with 17q and 18q markers in a breast/ovarian cancer family.
Milner BJ; Allan LA; Kelly KF; Cruickshank D; Hall M; Johnston A; Kitchener H; Parkin D; Haites N
Am J Hum Genet; 1993 Apr; 52(4):761-6. PubMed ID: 8096360
[TBL] [Abstract][Full Text] [Related]
16. Genetic risk and screening techniques for epithelial ovarian cancer. ACOG Committee Opinion: Committee on Gynecologic Practice. Number 117--December 1992.
Int J Gynaecol Obstet; 1993 Jun; 41(3):321-3. PubMed ID: 8102999
[No Abstract] [Full Text] [Related]
17. Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.
Mazoyer S; Lalle P; Narod SA; Bignon YJ; Courjal F; Jamot B; Dutrillaux B; Stoppa-Lyonnett D; Sobol H
Am J Hum Genet; 1993 Apr; 52(4):754-60. PubMed ID: 8096359
[TBL] [Abstract][Full Text] [Related]
18. Hereditary ovarian cancer.
Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
Nakonechny QB; Gilks CB
Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.
Komata D; Yahata T; Kodama S; Koyama Y; Takeda N; Tajima K; Makino H; Sato N; Muto I; Hatakeyama K; Tanaka K
J Obstet Gynaecol Res; 2009 Oct; 35(5):912-7. PubMed ID: 20149041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
